As of Jan 19
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Sellas Life Sciences Group Inc have a median target of 120.00, with a high estimate of 120.00 and a low estimate of 120.00. The median estimate represents a +1,651.82% increase from the last price of 6.85.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.